Process for the preparation of 4-(3-chloro-2-fluoro-anilino)-7-methoxy6-[1- (N-methylcarbamoylmethyl)-piperidin-4yl]quinazoline

Details for Australian Patent Application No. 2010240717 (hide)

Owner AstraZeneca AB

Inventors Boardman, Kay Alison; Cunningham, Oliver Robert; Goundry, William; Laffan, David Dermot Patrick

Agent Davies Collison Cave

Pub. Number AU-A-2010240717

PCT Pub. Number WO2010/122340

Priority 61/171,994 23.04.09 US

Filing date 22 April 2010

Wipo publication date 28 October 2010

International Classifications

C07D 211/46 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07C 257/12 (2006.01) Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

27 October 2011 PCT application entered the National Phase

  PCT publication WO2010/122340 Priority application(s): WO2010/122340

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010240721-Nozzle capable of maximizing the quantity of movement produced by a two-phase flow through the relief of a saturating flow

2010240715-Tie strip